These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 5080721)

  • 1. Failure to demonstrate transformation of lymphocytes of patients with isoniazid-associated hepatitis.
    Dove JT; Chaparas SD; Hedrick SR
    Am Rev Respir Dis; 1972 Sep; 106(3):485-7. PubMed ID: 5080721
    [No Abstract]   [Full Text] [Related]  

  • 2. Validity of serum glutamic oxalacetic transaminase determinations in isoniazid recipients.
    Bailey WC; Taylor SL; Samuels MS; Dascomb HE; Ziskind M; DeRouen TA
    Am Rev Respir Dis; 1973 Apr; 107(4):670-2. PubMed ID: 4697675
    [No Abstract]   [Full Text] [Related]  

  • 3. Lymphocyte stimulation induced by halothane in patients with hepatitis following exposure to halothane.
    Paronetto F; Popper H
    N Engl J Med; 1970 Aug; 283(6):277-80. PubMed ID: 5448331
    [No Abstract]   [Full Text] [Related]  

  • 4. Isoniazid-associated hepatitis. Report of an outbreak.
    Garibaldi RA; Drusin RE; Ferebee SH; Gregg MB
    Am Rev Respir Dis; 1972 Sep; 106(3):357-65. PubMed ID: 5080707
    [No Abstract]   [Full Text] [Related]  

  • 5. Liver enzyme disturbances during isoniazid chemoprophylaxis in children.
    Beaudry PH; Brickman HF; Wise MB; MacDougall D
    Am Rev Respir Dis; 1974 Nov; 110(5):581-4. PubMed ID: 4429254
    [No Abstract]   [Full Text] [Related]  

  • 6. Letter: Disturbed hepatic function during isoniazid chemoprophylaxis.
    Levy SA
    Am Rev Respir Dis; 1973 Dec; 108(6):1452-3. PubMed ID: 4751738
    [No Abstract]   [Full Text] [Related]  

  • 7. Lymphocyte transformation and alcoholic liver injury.
    Sorrell MF; Leevy CM
    Gastroenterology; 1972 Dec; 63(6):1020-5. PubMed ID: 4639357
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation of isoniazid-associated hepatitis by immunological tests.
    Warrington RJ; Tse KS; Gorski BA; Schwenk R; Sehon AH
    Clin Exp Immunol; 1978 Apr; 32(1):97-104. PubMed ID: 668195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The predictive value of the lymphocyte transformation test in isoniazid-associated hepatitis.
    Warrington RJ; McPhilips-Feener S; Rutherford WJ
    Clin Allergy; 1982 May; 12(3):217-22. PubMed ID: 7105389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isoniazid hepatitis.
    Maddrey WC; Boitnott JK
    Ann Intern Med; 1973 Jul; 79(1):1-12. PubMed ID: 4721174
    [No Abstract]   [Full Text] [Related]  

  • 11. Editorial: Isoniazid-associated hepatitis. Reconsideration of the indications for administration of isoniazid.
    Israel HL
    Gastroenterology; 1975 Aug; 69(2):539-42. PubMed ID: 1150056
    [No Abstract]   [Full Text] [Related]  

  • 12. Isoniazid-associated hepatitis deaths: a review of available information.
    Israel HL; Gottlieb JE
    Am Rev Respir Dis; 1992 Dec; 146(6):1643; author reply 1644. PubMed ID: 1456590
    [No Abstract]   [Full Text] [Related]  

  • 13. Disturbed hepatic function during isoniazid chemoprophylaxis. Monitoring the hepatic function of 427 hospital employees receiving isoniazid chemoprophylaxis for tuberculosis.
    Bailey WC; Taylor SL; Dascomb HE; Greenberg HB; Ziskind MM
    Am Rev Respir Dis; 1973 Apr; 107(4):523-9. PubMed ID: 4697661
    [No Abstract]   [Full Text] [Related]  

  • 14. Fatal hepatic necrosis due to isoniazid chemoprophylaxis in a 15-year-old girl.
    Vanderhoof JA; Ament ME
    J Pediatr; 1976 May; 88(5):867-8. PubMed ID: 1271153
    [No Abstract]   [Full Text] [Related]  

  • 15. Isoniazid hepatotoxicity in children.
    Rapp RS; Campbell RW; Howell JC; Kendig EL
    Am Rev Respir Dis; 1978 Oct; 118(4):794-6. PubMed ID: 309296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a modified lymphocyte transformation test for diagnosing drug-induced liver injury associated with an adaptive immune response.
    Whritenour J; Ko M; Zong Q; Wang J; Tartaro K; Schneider P; Olson E; Van Volkenburg M; Serrano J; Hayashi P; Fontana R; Chalasani N; Bonkovsky HL
    J Immunotoxicol; 2017 Dec; 14(1):31-38. PubMed ID: 28121193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical hepatotoxicity of isoniazid in children.
    Stein MT; Liang D
    Pediatrics; 1979 Oct; 64(4):499-505. PubMed ID: 492816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isoniazid liver injury: clinical spectrum, pathology, and probable pathogenesis.
    Mitchell JR; Zimmerman HJ; Ishak KG; Thorgeirsson UP; Timbrell JA; Snodgrass WR; Nelson SD
    Ann Intern Med; 1976 Feb; 84(2):181-92. PubMed ID: 766682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Isoniazide hepatic damage as opposed to prophylactic treatment for tuberculosis].
    Oliven A; Odeh M; Bassan H
    Harefuah; 1992 Feb; 122(4):254-7. PubMed ID: 1563691
    [No Abstract]   [Full Text] [Related]  

  • 20. Isoniazid treatment for tuberculosis.
    Stadler ET; Steiner M
    N Engl J Med; 1971 Apr; 284(13):730-1. PubMed ID: 4993672
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.